{
     "PMID": "23871488",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20131118",
     "LR": "20130909",
     "IS": "1872-8421 (Electronic) 0165-5728 (Linking)",
     "VI": "262",
     "IP": "1-2",
     "DP": "2013 Sep 15",
     "TI": "The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.",
     "PG": "66-71",
     "LID": "10.1016/j.jneuroim.2013.07.002 [doi] S0165-5728(13)00174-4 [pii]",
     "AB": "Oxidative stress and mitochondrial dysfunction appear to contribute to neurodegenerative processes during multiple sclerosis (MS). Thus, antioxidants may represent a therapeutic option for MS. The antioxidant idebenone was proven to be beneficial in Friedreich's ataxia and Leber's hereditary optic neuropathy, two disorders caused by mitochondrial alterations. Here we showed that idebenone protected neuronal HT22 cells from glutamate-induced death in vitro. However, in experimental autoimmune encephalomyelitis, idebenone failed to affect disease incidence or onset when applied preventively, or to reduce disease severity when applied therapeutically. Histopathological examination of CNS from idebenone treated mice showed no improvement in inflammation, demyelination, or axonal damage. Thus, we hypothesize that idebenone treatment will likely not benefit patients with MS.",
     "CI": [
          "(c) 2013."
     ],
     "FAU": [
          "Fiebiger, Sebastian M",
          "Bros, Helena",
          "Grobosch, Thomas",
          "Janssen, Antonia",
          "Chanvillard, Coralie",
          "Paul, Friedemann",
          "Dorr, Jan",
          "Millward, Jason M",
          "Infante-Duarte, Carmen"
     ],
     "AU": [
          "Fiebiger SM",
          "Bros H",
          "Grobosch T",
          "Janssen A",
          "Chanvillard C",
          "Paul F",
          "Dorr J",
          "Millward JM",
          "Infante-Duarte C"
     ],
     "AD": "Institute for Medical Immunology, Charite-Universitatmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20130718",
     "PL": "Netherlands",
     "TA": "J Neuroimmunol",
     "JT": "Journal of neuroimmunology",
     "JID": "8109498",
     "RN": [
          "0 (Antioxidants)",
          "1339-63-5 (Ubiquinone)",
          "HB6PN45W4J (idebenone)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antioxidants/administration & dosage/*pharmacology",
          "Chronic Disease",
          "Disease Models, Animal",
          "Encephalomyelitis, Autoimmune, Experimental/chemically induced/*drug therapy/pathology",
          "Female",
          "Hippocampus/cytology/*drug effects/pathology",
          "Inflammation/drug therapy",
          "Mice",
          "Mice, Inbred C57BL",
          "Neurons/cytology/drug effects/pathology",
          "Severity of Illness Index",
          "Ubiquinone/administration & dosage/*analogs & derivatives/cerebrospinal fluid/pharmacology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "EAE",
          "Idebenone",
          "Inflammation",
          "Multiple sclerosis",
          "Oxidative stress"
     ],
     "EDAT": "2013/07/23 06:00",
     "MHDA": "2013/11/19 06:00",
     "CRDT": [
          "2013/07/23 06:00"
     ],
     "PHST": [
          "2013/03/05 00:00 [received]",
          "2013/06/08 00:00 [revised]",
          "2013/07/02 00:00 [accepted]",
          "2013/07/23 06:00 [entrez]",
          "2013/07/23 06:00 [pubmed]",
          "2013/11/19 06:00 [medline]"
     ],
     "AID": [
          "S0165-5728(13)00174-4 [pii]",
          "10.1016/j.jneuroim.2013.07.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neuroimmunol. 2013 Sep 15;262(1-2):66-71. doi: 10.1016/j.jneuroim.2013.07.002. Epub 2013 Jul 18.",
     "term": "hippocampus"
}